US 9662327
Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer
granted A61KA61K31/496A61K31/519
Quick answer
US patent 9662327 (Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer) held by Agios Pharmaceuticals, Inc. expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/496, A61K31/519, A61K31/551, A61P